Sabra Healthcare Reit Stock Probability of Future Stock Price Finishing Over 23.03

SBRA Stock  USD 17.08  0.17  1.01%   
Sabra Healthcare's future price is the expected price of Sabra Healthcare instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Sabra Healthcare REIT performance during a given time horizon utilizing its historical volatility. Check out Sabra Healthcare Backtesting, Sabra Healthcare Valuation, Sabra Healthcare Correlation, Sabra Healthcare Hype Analysis, Sabra Healthcare Volatility, Sabra Healthcare History as well as Sabra Healthcare Performance.
  
At present, Sabra Healthcare's Price To Sales Ratio is projected to decrease significantly based on the last few years of reporting. The current year's Price Earnings Ratio is expected to grow to 251.83, whereas Price Earnings To Growth Ratio is projected to grow to (1.94). Please specify Sabra Healthcare's target price for which you would like Sabra Healthcare odds to be computed.

Sabra Healthcare Target Price Odds to finish over 23.03

The tendency of Sabra Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move over $ 23.03  or more in 90 days
 17.08 90 days 23.03 
near 1
Based on a normal probability distribution, the odds of Sabra Healthcare to move over $ 23.03  or more in 90 days from now is near 1 (This Sabra Healthcare REIT probability density function shows the probability of Sabra Stock to fall within a particular range of prices over 90 days) . Probability of Sabra Healthcare REIT price to stay between its current price of $ 17.08  and $ 23.03  at the end of the 90-day period is roughly 97.0 .
Given the investment horizon of 90 days Sabra Healthcare has a beta of 0.27. This usually implies as returns on the market go up, Sabra Healthcare average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Sabra Healthcare REIT will be expected to be much smaller as well. Additionally Sabra Healthcare REIT has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   Sabra Healthcare Price Density   
       Price  

Predictive Modules for Sabra Healthcare

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Sabra Healthcare REIT. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
15.4717.0418.61
Details
Intrinsic
Valuation
LowRealHigh
14.5216.0917.66
Details
Naive
Forecast
LowNextHigh
15.1516.7118.28
Details
14 Analysts
Consensus
LowTargetHigh
13.3114.6316.24
Details

Sabra Healthcare Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Sabra Healthcare is not an exception. The market had few large corrections towards the Sabra Healthcare's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Sabra Healthcare REIT, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Sabra Healthcare within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-0.16
β
Beta against Dow Jones0.27
σ
Overall volatility
0.60
Ir
Information ratio -0.12

Sabra Healthcare Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Sabra Healthcare for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Sabra Healthcare REIT can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Sabra Healthcare generated a negative expected return over the last 90 days
Sabra Healthcare REIT currently holds 2.45 B in liabilities with Debt to Equity (D/E) ratio of 0.76, which is about average as compared to similar companies. Sabra Healthcare REIT has a current ratio of 0.76, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Sabra Healthcare's use of debt, we should always consider it together with its cash and equity.
Sabra Healthcare has a poor financial position based on the latest SEC disclosures
Over 99.0% of Sabra Healthcare shares are owned by institutional investors
On 29th of November 2024 Sabra Healthcare paid $ 0.3 per share dividend to its current shareholders
Latest headline from investing.com: Sabra Health Care REITs SWOT analysis stock performance solid amid fair valuation

Sabra Healthcare Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Sabra Stock often depends not only on the future outlook of the current and potential Sabra Healthcare's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Sabra Healthcare's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding232.8 M
Cash And Short Term Investments41.3 M

Sabra Healthcare Technical Analysis

Sabra Healthcare's future price can be derived by breaking down and analyzing its technical indicators over time. Sabra Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Sabra Healthcare REIT. In general, you should focus on analyzing Sabra Stock price patterns and their correlations with different microeconomic environments and drivers.

Sabra Healthcare Predictive Forecast Models

Sabra Healthcare's time-series forecasting models is one of many Sabra Healthcare's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Sabra Healthcare's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Sabra Healthcare REIT

Checking the ongoing alerts about Sabra Healthcare for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Sabra Healthcare REIT help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Sabra Healthcare generated a negative expected return over the last 90 days
Sabra Healthcare REIT currently holds 2.45 B in liabilities with Debt to Equity (D/E) ratio of 0.76, which is about average as compared to similar companies. Sabra Healthcare REIT has a current ratio of 0.76, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Sabra Healthcare's use of debt, we should always consider it together with its cash and equity.
Sabra Healthcare has a poor financial position based on the latest SEC disclosures
Over 99.0% of Sabra Healthcare shares are owned by institutional investors
On 29th of November 2024 Sabra Healthcare paid $ 0.3 per share dividend to its current shareholders
Latest headline from investing.com: Sabra Health Care REITs SWOT analysis stock performance solid amid fair valuation
When determining whether Sabra Healthcare REIT offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Sabra Healthcare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Sabra Healthcare Reit Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Sabra Healthcare Reit Stock:
Is Diversified REITs space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sabra Healthcare. If investors know Sabra will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sabra Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.111
Dividend Share
1.2
Earnings Share
0.41
Revenue Per Share
2.943
Quarterly Revenue Growth
0.107
The market value of Sabra Healthcare REIT is measured differently than its book value, which is the value of Sabra that is recorded on the company's balance sheet. Investors also form their own opinion of Sabra Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Sabra Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sabra Healthcare's market value can be influenced by many factors that don't directly affect Sabra Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sabra Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sabra Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sabra Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.